<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genet</journal-id><journal-title>BMC Genetics</journal-title><issn pub-type="epub">1471-2156</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15720714</article-id><article-id pub-id-type="pmc">PMC551616</article-id><article-id pub-id-type="publisher-id">1471-2156-6-9</article-id><article-id pub-id-type="doi">10.1186/1471-2156-6-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" corresp="yes" contrib-type="author"><name><surname>Maier</surname><given-names>Lisa M</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lisa.maier@cimr.cam.ac.uk</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Smyth</surname><given-names>Deborah J</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>deborah.smyth@cimr.cam.ac.uk</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Vella</surname><given-names>Adrian</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>adrian.vella@mayo.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Payne</surname><given-names>Felicity</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>felicity.payne@cimr.cam.ac.uk</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Cooper</surname><given-names>Jason D</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jason.cooper@cimr.cam.ac.uk</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Pask</surname><given-names>Rebecca</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rebecca.pask@cimr.cam.ac.uk</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Lowe</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>chris.lowe@cimr.cam.ac.uk</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Hulme</surname><given-names>John</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>john.hulme@cimr.cam.ac.uk</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Smink</surname><given-names>Luc J</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>luc.smink@cimr.cam.ac.uk</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Fraser</surname><given-names>Heather</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>heather.fraser@cimr.cam.ac.uk</email></contrib><contrib id="A11" contrib-type="author"><name><surname>Moule</surname><given-names>Carolyn</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>carolyn.moule@cimr.cam.ac.uk</email></contrib><contrib id="A12" contrib-type="author"><name><surname>Hunter</surname><given-names>Kara M</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>kara.hunter@cimr.cam.ac.uk</email></contrib><contrib id="A13" contrib-type="author"><name><surname>Chamberlain</surname><given-names>Giselle</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>giselle.chamberlain@cimr.cam.ac.uk</email></contrib><contrib id="A14" contrib-type="author"><name><surname>Walker</surname><given-names>Neil</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>neil.walker@cimr.cam.ac.uk</email></contrib><contrib id="A15" contrib-type="author"><name><surname>Nutland</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>sarah.nutland@cimr.cam.ac.uk</email></contrib><contrib id="A16" contrib-type="author"><name><surname>Undlien</surname><given-names>Dag E</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>d.e.undlien@ioks.uio.no</email></contrib><contrib id="A17" contrib-type="author"><name><surname>R&#x000f8;nningen</surname><given-names>Kjersti S</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>kjersti.skjold.ronningen@fhi.no</email></contrib><contrib id="A18" contrib-type="author"><name><surname>Guja</surname><given-names>Cristian</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>cristi_guja@fx.ro</email></contrib><contrib id="A19" contrib-type="author"><name><surname>Ionescu-T&#x000ee;rgovi&#x0015f;te</surname><given-names>Constantin</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>institut@paulescu.ro</email></contrib><contrib id="A20" contrib-type="author"><name><surname>Savage</surname><given-names>David A</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>d.savage@qub.ac.uk</email></contrib><contrib id="A21" contrib-type="author"><name><surname>Strachan</surname><given-names>David P</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>sgjd950@sghms.ac.uk</email></contrib><contrib id="A22" contrib-type="author"><name><surname>Peterson</surname><given-names>Laurence B</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>larry_peterson@merck.com</email></contrib><contrib id="A23" contrib-type="author"><name><surname>Todd</surname><given-names>John A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>john.todd@cimr.cam.ac.uk</email></contrib><contrib id="A24" contrib-type="author"><name><surname>Wicker</surname><given-names>Linda S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>linda.wicker@cimr.cam.ac.uk</email></contrib><contrib id="A25" corresp="yes" contrib-type="author"><name><surname>Twells</surname><given-names>Rebecca C</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rebecca.twells@cimr.cam.ac.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Wellcome Trust/MRC Building, Hills Road, Cambridge, UK</aff><aff id="I2"><label>2</label>Institute and Department of Medical Genetics, Ulleval University Hospital, University of Oslo, Oslo, Norway</aff><aff id="I3"><label>3</label>Laboratory of Molecular Epidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway</aff><aff id="I4"><label>4</label>Clinic of Diabetes, Institute of Diabetes, Nutrition and Metabolic Diseases 'N. Paulescu', Bucharest, Romania</aff><aff id="I5"><label>5</label>Department of Medical Genetics, Queen's University Belfast, Belfast City Hospital, Belfast, UK</aff><aff id="I6"><label>6</label>Department of Community Health Sciences, St George's Hospital Medical School, London, UK</aff><aff id="I7"><label>7</label>Department of Pharmacology, Merck Research Laboratories, Rahway, New Jersey, USA</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>18</day><month>2</month><year>2005</year></pub-date><volume>6</volume><fpage>9</fpage><lpage>9</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2156/6/9"/><history><date date-type="received"><day>1</day><month>12</month><year>2004</year></date><date date-type="accepted"><day>18</day><month>2</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2005 Maier et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Maier et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Maier
               M
               Lisa
               
               lisa.maier@cimr.cam.ac.uk
            </dc:author><dc:title>
            Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes
         </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>BMC Genetics 6(1): 9-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2156(2005)6:1&#x0003c;9&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2156</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>One strategy to help identify susceptibility genes for complex, multifactorial diseases is to map disease loci in a representative animal model of the disorder. The nonobese diabetic (NOD) mouse is a model for human type 1 diabetes. Linkage and congenic strain analyses have identified several NOD mouse <italic>Idd </italic>(insulin dependent diabetes) loci, which have been mapped to small chromosome intervals, for which the orthologous regions in the human genome can be identified. Here, we have conducted re-sequencing and association analysis of six orthologous genes identified in NOD <italic>Idd </italic>loci: <italic>NRAMP1/SLC11A1 </italic>(orthologous to <italic>Nramp1/Slc11a1 </italic>in <italic>Idd5.2</italic>), <italic>FRAP1 </italic>(orthologous to <italic>Frap1 </italic>in <italic>Idd9.2</italic>), <italic>4-1BB/CD137/TNFRSF9 </italic>(orthologous to <italic>4-1bb/Cd137/Tnrfrsf9 </italic>in <italic>Idd9.3</italic>), <italic>CD101/IGSF2 </italic>(orthologous to <italic>Cd101/Igsf2 </italic>in <italic>Idd10</italic>), <italic>B2M </italic>(orthologous to <italic>B2m </italic>in <italic>Idd13</italic>) and <italic>VAV3 </italic>(orthologous to <italic>Vav3 </italic>in <italic>Idd18</italic>).</p></sec><sec><title>Results</title><p>Re-sequencing of a total of 110 kb of DNA from 32 or 96 type 1 diabetes cases yielded 220 single nucleotide polymorphisms (SNPs). Sixty-five SNPs, including 54 informative tag SNPs, and a microsatellite were selected and genotyped in up to 1,632 type 1 diabetes families and 1,709 cases and 1,829 controls.</p></sec><sec><title>Conclusion</title><p>None of the candidate regions showed evidence of association with type 1 diabetes (<italic>P </italic>values &#x0003e; 0.2), indicating that common variation in these key candidate genes does not play a major role in type 1 diabetes susceptibility in the European ancestry populations studied.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Type 1 diabetes is a common, multifactorial disease believed to be caused in a proportion of cases by an autoimmune destruction of pancreatic &#x003b2;-cells by an inflammatory infiltrate comprising T lymphocytes, dendritic cells and macrophages. This process results from a complex interaction between genetic and environmental risk factors. Genetically, it is under the control of the major histocompatibility complex (MHC) [<xref ref-type="bibr" rid="B1">1</xref>] and many other genes of smaller effect and mostly unknown identity.</p><p>A murine model of type 1 diabetes, the NOD mouse, spontaneously develops an autoimmune-mediated diabetes that has many similarities to the human disease. It is likely that components of the pathophysiology and genetic predisposition are conserved across species, and indeed two loci have already been shown to affect type 1 diabetes susceptibility in both species, namely the immunoregulatory MHC HLA class II and CTLA-4 genes. The other causative gene(s) in the known <italic>Idd </italic>regions controlling type 1 diabetes susceptibility in the NOD mouse could also determine susceptibility in humans, even though this depends on the frequency of susceptibility alleles in human populations, which affects statistical power, and that the correct candidate gene has been chosen from the <italic>Idd </italic>interval. These <italic>Idd </italic>intervals might contain many genes, including several involved in the immune response [<xref ref-type="bibr" rid="B2">2</xref>]. Nevertheless, in contrast to studies in humans based on linkage, the localisation of a type 1 diabetes locus to a specific chromosome region in the mouse genome using congenic strain breeding defines with certainty a set of genes, one or more of which is definitely a susceptibility gene [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p><p>The central importance of T cell development and function in type 1 diabetes is evident from the susceptibility genes identified so far. The MHC class II genes are important etiologically in two rat models of type 1 diabetes, the Biobreeding (BB) and KDP strains [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>], the NOD mouse strain [<xref ref-type="bibr" rid="B3">3</xref>] and in humans [<xref ref-type="bibr" rid="B1">1</xref>], with their essential function not only in T cell activation and expansion but also in T cell repertoire formation in the thymus and clonal deletion of autoreactive cells. The BB rat type 1 diabetes susceptibility locus <italic>Ian4/Iddm1 </italic>[<xref ref-type="bibr" rid="B7">7</xref>] affects T lymphocyte development whereas the <italic>Cblb </italic>(KDP rat) [<xref ref-type="bibr" rid="B8">8</xref>] and <italic>CTLA4 </italic>[<xref ref-type="bibr" rid="B9">9</xref>] (in humans and NOD mice) susceptibility genes highlight the importance of the regulation of T cell activation, expansion and homeostasis in the periphery, and perhaps in the thymus as well.</p><p>In our selection of candidate genes within NOD congenic intervals, we have, therefore, biased our choice towards immune-related genes such as <italic>Il2 </italic>[<xref ref-type="bibr" rid="B2">2</xref>], <italic>Cd101 </italic>[<xref ref-type="bibr" rid="B10">10</xref>] and <italic>Nramp1/Slc11a1 </italic>[<xref ref-type="bibr" rid="B11">11</xref>]. From each of <italic>Idd5.2 </italic>[<xref ref-type="bibr" rid="B11">11</xref>], <italic>Idd9.2 </italic>[<xref ref-type="bibr" rid="B12">12</xref>], <italic>Idd9.3 </italic>[<xref ref-type="bibr" rid="B12">12</xref>], <italic>Idd10 </italic>[<xref ref-type="bibr" rid="B10">10</xref>], <italic>Idd13 </italic>[<xref ref-type="bibr" rid="B13">13</xref>] and <italic>Idd18 </italic>[<xref ref-type="bibr" rid="B14">14</xref>] we chose immune-associated functional candidate genes to study in human type 1 diabetes: <italic>Nramp1</italic>/<italic>Slc11a1 </italic>from <italic>Idd5.2 </italic>[<xref ref-type="bibr" rid="B11">11</xref>]; <italic>Frap1 </italic>from <italic>Idd9.2 </italic>(unpublished); <italic>4-1bb/Cd137/Tnfrsf9 </italic>from <italic>Idd9.3 </italic>[<xref ref-type="bibr" rid="B12">12</xref>] (unpublished); <italic>Cd101/Igsf2 </italic>from <italic>Idd10 </italic>[<xref ref-type="bibr" rid="B10">10</xref>]; <italic>B2m </italic>from <italic>Idd13 </italic>[<xref ref-type="bibr" rid="B15">15</xref>] and <italic>Vav3 </italic>from <italic>Idd18 </italic>(note that very recent congenic strain mapping results indicate that the <italic>Idd18 </italic>interval contains only one gene with known immunological function, namely the VAV3 gene, and this will be published elsewhere). Table <xref ref-type="table" rid="T1">1</xref> summarises the main features of the six human candidate genes.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>NOD mouse <italic>Idd </italic>loci, location of their human orthologous regions, and selected functional candidate genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold><italic>Idd</italic></bold></td><td align="left"><bold>Mouse chromosome</bold></td><td align="left"><bold>Interval size (Mb)</bold></td><td align="left"><bold>Number of genes</bold></td><td align="left"><bold>Functional candidate genes in mouse <italic>Idd </italic>intervals</bold></td><td align="left"><bold>Location of human orthologous region</bold></td><td align="left"><bold>Human orthologue genes</bold></td><td align="left"><bold>Known gene function and previously reported disease associations</bold></td></tr></thead><tbody><tr><td align="left"><italic>Idd5.2</italic></td><td align="left">1</td><td align="left">1.7</td><td align="left">47</td><td align="left"><italic>Idd5.2: Nramp1/Slc11a1</italic></td><td align="left">2q35</td><td align="left"><italic>NRAMP1/SLC11A1</italic></td><td align="left">Endosomal/lysosomal acidification and associated with protection from infectious disease and susceptibility to autoimmune disease</td></tr><tr><td align="left"><italic>Idd9.2</italic></td><td align="left">4</td><td align="left">1.1</td><td align="left">13</td><td align="left"><italic>Idd9.2: Frap1</italic></td><td align="left">1p32</td><td align="left"><italic>FRAP1</italic></td><td align="left">FKBP12-rapamycin associated protein of mTOR. Candidate tumour suppressor gene, whose function in apoptosis is influenced by allelic variation</td></tr><tr><td align="left"><italic>Idd9.3</italic></td><td align="left">4</td><td align="left">1.2</td><td align="left">13</td><td align="left"><italic>Idd9.3: 4-1bb</italic></td><td align="left">1p36</td><td align="left"><italic>4-1BB</italic></td><td align="left">Role in enhancing and regulating CD4<sup>+</sup>, CD8<sup>+ </sup>T cells and dendritic cells</td></tr><tr><td align="left"><italic>Idd10</italic></td><td align="left">3</td><td align="left">0.95</td><td align="left">7</td><td align="left"><italic>Idd10: Cd101</italic></td><td align="left">1p12</td><td align="left"><italic>CD101</italic></td><td align="left">Co-stimulatory receptor of T cells</td></tr><tr><td align="left"><italic>Idd13</italic></td><td align="left">2</td><td align="left">6 cM</td><td align="left">&#x0003e; 50*</td><td align="left"><italic>Idd13: B2m</italic></td><td align="left">15q21</td><td align="left"><italic>B2M</italic></td><td align="left">Required for antigen presentation by MHC class I molecules and the development of diabetes in NOD mice</td></tr><tr><td align="left"><italic>Idd18</italic></td><td align="left">3</td><td align="left">0.7</td><td align="left">2</td><td align="left"><italic>Idd18: Vav3</italic></td><td align="left">1p13-p21</td><td align="left"><italic>VAV3</italic></td><td align="left">Guanine nucleotide exchange factor involved in signalling of T and B cell receptors</td></tr></tbody></table><table-wrap-foot><p>*Estimated number of genes. A version of this table is provided in <xref ref-type="supplementary-material" rid="S1">Additional file 1</xref> with the supporting published references (see <xref ref-type="supplementary-material" rid="S1">Additional file 1</xref>).</p></table-wrap-foot></table-wrap></sec><sec><title>Results and discussion</title><p>A tag SNP approach to test for association was adopted for all genes, except for <italic>4-1BB </italic>[<xref ref-type="bibr" rid="B16">16</xref>], in order to achieve cost-savings in genotyping. A multi-locus test was used to evaluate the association between type 1 diabetes and the tag SNPs due to linkage disequilibrium (LD) with one or more causal variants [<xref ref-type="bibr" rid="B17">17</xref>]. Coding and untranslated regions of <italic>NRAMP1 </italic>(MIM 600266), <italic>FRAP1 </italic>(MIM 601231), <italic>4-1BB </italic>(MIM 602250), <italic>CD101 </italic>(MIM 604516), <italic>B2M </italic>(MIM 109700) and <italic>VAV3 </italic>(MIM 605541) were re-sequenced in 32 or 96 randomly chosen UK white patients with type 1 diabetes to identify SNPs and for the selection of tag SNPs. As LD between <italic>4-1BB </italic>SNPs was weak, eight out of nine common SNPs were genotyped (minor allele frequency, MAF &#x02265; 0.03; one SNP could not be genotyped due to assay technical difficulties) and analysed using single-locus tests.</p><p>A total of 110 kb of re-sequenced regions yielded 220 SNPs, including six deletion/insertion polymorphisms (DIPs) (see Table <xref ref-type="table" rid="T2">2</xref> and <xref ref-type="supplementary-material" rid="S2">Additional files 2</xref>, <xref ref-type="supplementary-material" rid="S3">3</xref>,<xref ref-type="supplementary-material" rid="S4">4</xref>,<xref ref-type="supplementary-material" rid="S5">5</xref>,<xref ref-type="supplementary-material" rid="S6">6</xref> and<xref ref-type="supplementary-material" rid="S7">7</xref>). No coding changes or obvious candidates for variants that could change the function or expression of <italic>4-1BB, FRAP1</italic>, or <italic>B2M </italic>were observed. A synonymous change was detected in exon 3 of <italic>NRAMP1 </italic>(MAF = 0.32) and a non-synonymous SNP (nsSNP) in exon 15 (MAF = 0.02), causing a conservative amino acid change: Asp543Asn (DIL5202/ss23142243). Interestingly, as in the case of its mouse orthologue [<xref ref-type="bibr" rid="B10">10</xref>], several nsSNPs were discovered in exons 3, 4, 5, and 8 of <italic>CD101 </italic>(see <xref ref-type="supplementary-material" rid="S5">Additional file 5</xref>). Re-sequencing of the three alternative transcripts of <italic>VAV3</italic>, called <italic>VAV3 </italic>(27 exons), <italic>VAV3&#x003b2; </italic>(unique exon 1 and exons 4 to 27) and <italic>VAV3.1 </italic>(unique exon 18 and exons 19 to 27) yielded six exonic SNPs (see <xref ref-type="supplementary-material" rid="S7">Additional file 7</xref>). Two SNPs, Pro611Ser (MAF = 0.13) and Gln613His (MAF = 0.13) are located in the SH3 domain of the VAV3 protein and, therefore, could result in VAV3 having altered protein interactions. In order to facilitate the computation of the selection of tag SNPs, <italic>VAV3 </italic>was divided into three sections as suggested by the pattern of LD across the gene.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Summary of the re-sequencing study. Gene size, number of exons, amount of re-sequenced DNA for each gene (including 5' and 3' regions of gene), sequencing panel, and number of SNPs identified.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Locus</bold></td><td align="center"><bold>Genomic size (kb)</bold></td><td align="center"><bold>n exons</bold></td><td align="center"><bold>Re-sequenced region (kb)</bold></td><td align="center"><bold>n cases re-sequenced</bold></td><td align="center"><bold>n SNPs</bold></td></tr></thead><tbody><tr><td align="center"><italic>NRAMP1</italic></td><td align="center">13.58</td><td align="center">15 (7,13)*</td><td align="center">12.13</td><td align="center">32</td><td align="center">20</td></tr><tr><td align="center"><italic>4-1BB</italic></td><td align="center">20.50</td><td align="center">8</td><td align="center">13.66</td><td align="center">96</td><td align="center">23</td></tr><tr><td align="center"><italic>FRAP1</italic></td><td align="center">60.98</td><td align="center">58</td><td align="center">30.88</td><td align="center">32</td><td align="center">55</td></tr><tr><td align="center"><italic>CD101</italic></td><td align="center">34.61</td><td align="center">10</td><td align="center">15.90</td><td align="center">96</td><td align="center">31</td></tr><tr><td align="center"><italic>B2M</italic></td><td align="center">6.61</td><td align="center">4</td><td align="center">9.33</td><td align="center">32</td><td align="center">13</td></tr><tr><td align="center"><italic>VAV3</italic></td><td align="center">393.70</td><td align="center">27 (25,10)*</td><td align="center">27.69</td><td align="center">96</td><td align="center">78</td></tr><tr><td align="center"><italic>Total</italic></td><td align="center"><italic>529.98</italic></td><td align="center"><italic>122</italic></td><td align="center"><italic>109.59</italic></td><td align="center"><italic>-</italic></td><td align="center"><italic>220</italic></td></tr></tbody></table><table-wrap-foot><p>* Number of exons in splice variants. n, number.</p></table-wrap-foot></table-wrap><p>Two common nsSNPs (MAF &#x02265; 0.05; DIL1521/rs7528153 and DIL3809/ss23142432) from <italic>VAV3 </italic>and a microsatellite from <italic>NRAMP1 </italic>were genotyped <italic>a priori </italic>in the whole family collection (step 1 and 2) and a single nsSNP from <italic>CD101 </italic>in step 1 families only (DIL3794/rs3754112). The nsSNP DIL3810/ss23142433 in <italic>VAV3 </italic>was not tested because it was in quite strong LD with DIL3809/ss23142432 (R<sup>2 </sup>= 0.64), so that only DIL3809/ss23142432 was genotyped. Note that in our tag approach, the two VAV3 nsSNPs (DIL1521/rs7528153 and DIL3809/ss23142432) were chosen deliberately as tag SNPs.</p><p>In a pragmatic, phased genotyping strategy, in step 1, the multi-locus test <italic>P </italic>values for association between type 1 diabetes and candidate gene tag SNPs all exceeded 0.2, as did the single-locus test <italic>P </italic>values for <italic>4-1BB </italic>SNPs. Consequently, we did not proceed to genotype in step 2 samples for any of the candidate genes (Table <xref ref-type="table" rid="T3">3</xref> and <xref ref-type="table" rid="T4">4</xref>). Note that none of the nsSNPs of <italic>VAV3 </italic>and <italic>CD101 </italic>or the microsatellite of <italic>NRAMP1 </italic>showed evidence of association (Table <xref ref-type="table" rid="T5">5</xref>). Allele A3 of the <italic>NRAMP1 </italic>microsatellite promoter (GT)<sub>n </sub>has previously shown linkage and association with autoimmune disease, and allele A2 with infectious disease susceptibility [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. The relative risks of allele A3 and genotype A3/A3 in our type 1 diabetes samples was 0.96 (95% CI = 0.94 &#x02013; 1.17) and 0.90 (95% CI = 0.70 &#x02013; 1.16), respectively.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Study design. Lengths of re-sequenced genomic regions, and number of tag SNPs or single SNPs genotyped in a pragmatic two-step genotyping design for <italic>NRAMP1</italic>, <italic>4-1BB</italic>, <italic>FRAP1</italic>, <italic>CD101</italic>, <italic>B2M</italic>, and <italic>VAV3</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Locus</bold></td><td align="center"><bold>Re-sequenced region (kb)</bold></td><td align="center"><bold>n common SNPs*</bold></td><td align="center"><bold>n tag SNPs</bold></td><td align="center"><bold>Genotyping strategy (step 1 &#x02192; step 2)</bold></td></tr></thead><tbody><tr><td align="center"><italic>NRAMP1</italic></td><td align="center">12.13</td><td align="center">12</td><td align="center">4</td><td align="center">Case-control &#x02192; Family set 1+2</td></tr><tr><td align="center"><italic>4-1BB</italic></td><td align="center">13.66</td><td align="center">8</td><td align="center">DIL4279/ss23142250</td><td align="center">Family set 1</td></tr><tr><td></td><td></td><td></td><td align="center">DIL4277/rs226476</td><td></td></tr><tr><td></td><td></td><td></td><td align="center">DIL4569/rs226478</td><td></td></tr><tr><td></td><td></td><td></td><td align="center">DIL4274/ss23142263</td><td></td></tr><tr><td></td><td></td><td></td><td align="center">DIL4570/ss23142264</td><td></td></tr><tr><td></td><td></td><td></td><td align="center">DIL4571/rs679563</td><td></td></tr><tr><td></td><td></td><td></td><td align="center">DIL4273/ss23142265</td><td></td></tr><tr><td></td><td></td><td></td><td align="center">DIL4272/ss23142270</td><td></td></tr><tr><td align="center"><italic>FRAP1</italic></td><td align="center">30.88</td><td align="center">21</td><td align="center">6</td><td align="center">Family set 1</td></tr><tr><td align="center"><italic>CD101</italic></td><td align="center">15.9</td><td align="center">18</td><td align="center">8</td><td align="center">Family set 1</td></tr><tr><td align="center"><italic>B2M</italic></td><td align="center">9.33</td><td align="center">10</td><td align="center">8</td><td align="center">Case-control &#x02192; Family set 1</td></tr><tr><td align="center"><italic>VAV3</italic></td><td align="center">27.69</td><td align="center">19 (block 1)<break/>18 (block 2)<break/>15 (block 3)</td><td align="center">7 (block 1)<break/>11 (block 2)<break/>10 (block 3)</td><td align="center">Family set 1</td></tr></tbody></table><table-wrap-foot><p>*For the selection of tag SNPs, minor allele frequencies of 0.03 were used for <italic>4-1BB</italic>, <italic>CD101 </italic>and <italic>FRAP1</italic>, and 0.05 for <italic>NRAMP1</italic>, <italic>B2M </italic>and <italic>VAV3</italic>. Note that the numbers of attempted and actual genotypes are given in <xref ref-type="supplementary-material" rid="S8">Additional file 8</xref>. n, number.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Disease association results. Multi-locus test <italic>P </italic>values, lengths of re-sequenced genomic regions, and number of tag SNPs or single SNPs genotyped in a two-step genotyping design for <italic>NRAMP1</italic>, <italic>4-1BB</italic>, <italic>FRAP1</italic>, <italic>CD101</italic>, <italic>B2M</italic>, and <italic>VAV3</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Locus</td><td align="center" colspan="2"><bold>Multilocus test <italic>P </italic>value/ Single-locus TDT <italic>P </italic>value</bold></td><td align="center"><bold>Case-control</bold></td><td align="center"><bold>Combined test <italic>P </italic>value</bold></td></tr><tr><td></td><td colspan="2"><hr></hr></td><td></td><td></td></tr><tr><td></td><td align="center"><bold>Family set 1</bold></td><td align="center"><bold>Family set 1 + 2</bold></td><td></td><td></td></tr></thead><tbody><tr><td align="center"><italic>NRAMP1</italic></td><td align="center">-</td><td align="center">0.56</td><td align="center">0.20</td><td align="center">0.68</td></tr><tr><td align="center"><italic>4-1BB</italic></td><td align="center">0.71</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.88</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.52</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.35</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.53</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.29</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.95</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.24</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center"><italic>FRAP1</italic></td><td align="center">0.44</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center"><italic>CD101</italic></td><td align="center">0.68</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center"><italic>B2M</italic></td><td align="center">0.90</td><td align="center">-</td><td align="center">0.11</td><td align="center">0.75</td></tr><tr><td align="center"><italic>VAV3</italic></td><td align="center">0.26 (block 1)</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.80 (block 2)</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td></td><td align="center">0.86 (block 3)</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Association analysis of non-synonymous SNPs. SNPs with allele frequencies above 0.05 and the <italic>NRAMP1 </italic>(GT)<sub>n </sub>microsatellite in up to 1,476 families with at least one affected offspring. N, number; T, number of transmissions; NT, number of untransmitted alleles; %T, percentage transmission of minor allele from heterozygous parents to type 1 diabetes offspring (obtained by transmission/disequilibrium test (TDT)); GTRR, genotype relative risk; <italic>P</italic>, probability value (two-sided).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Locus</bold></td><td align="left"><bold>Marker ID</bold></td><td align="left"><bold>Amino acid change/ alleles</bold></td><td align="left"><bold>Minor allele frequency</bold></td><td align="left"><bold>N families</bold></td><td align="left"><bold>T</bold></td><td align="left"><bold>NT</bold></td><td align="left"><bold>%T</bold></td><td align="left"><bold><italic>P</italic><sub>TDT</sub></bold></td><td align="left"><bold><italic>P</italic><sub>GTRR</sub></bold></td></tr></thead><tbody><tr><td align="left"><italic>VAV3</italic></td><td align="left">DIL1521</td><td align="left">Thr293Ser/T&#x0003e;A</td><td align="left">0.27</td><td align="left">1 476</td><td align="left">834</td><td align="left">840</td><td align="left">49.64</td><td align="left">0.77</td><td align="left">0.90</td></tr><tr><td></td><td align="left">DIL3809</td><td align="left">Pro611Ser/G&#x0003e;A</td><td align="left">0.13</td><td align="left">1 476</td><td align="left">417</td><td align="left">429</td><td align="left">49.29</td><td align="left">0.68</td><td align="left">0.84</td></tr><tr><td align="left"><italic>CD101</italic></td><td align="left">DIL3794</td><td align="left">Asn225Ser/A&#x0003e;G</td><td align="left">0.32</td><td align="left">652</td><td align="left">517</td><td align="left">515</td><td align="left">49.9</td><td align="left">0.95</td><td align="left">0.96</td></tr><tr><td align="left"><italic>NRAMP1</italic></td><td align="left">(GT)<sub>n</sub></td><td align="left">-</td><td align="left">-</td><td align="left">1 476</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">0.36</td></tr></tbody></table></table-wrap><p>With regards to our association study in humans, intronic and potential regulatory regions were not sequenced in the candidate genes since these cover large genomic regions, which will have to wait for much more extensive polymorphism maps [<xref ref-type="bibr" rid="B21">21</xref>]. For example, for <italic>VAV3</italic>, which spans almost 400 kb, less than 10% of the genomic region of <italic>VAV3 </italic>was re-sequenced to identify SNPs. The general importance of intronic and intergenic regulatory sequences as candidates for disease susceptibility is well recognised. Hence, potential unidentified causal variants in introns or flanking regions of the genes may have been missed, and remain a target for future analyses. Despite finding no evidence of association, it remains possible that there exists a common disease variant in one or more of the six candidate genes tested, which either has an effect smaller than would be detected with this study or is in much weaker LD with the tag SNPs than any other SNP known to us [<xref ref-type="bibr" rid="B22">22</xref>].</p><p>Finally, the possibility of one or more rare disease variants in a locus needs to be considered [<xref ref-type="bibr" rid="B23">23</xref>]. The best candidates for rare disease variants in the six genes studied here were thus genotyped in an expanded case-control collection of up to 3,704 type 1 diabetes cases and 3,930 controls: DIL5202/ss23142243 causes a non-conservative change in <italic>NRAMP </italic>(Asp543Asn, MAF = 0.02) and DIL3799/ss23142349 in <italic>CD101 </italic>(Val839Ile; MAF = 0.03). For both SNPs, <italic>P </italic>values above 0.05 were obtained (<italic>P </italic>= 0.19 for DIL5202/ss23142243 and <italic>P </italic>= 0.80 for DIL3799/ss23142349), therefore, making it less likely that these rare variants contribute to susceptibility to type 1 diabetes. Nevertheless, causal variants with MAFs less than 0.01 [<xref ref-type="bibr" rid="B24">24</xref>] may well remain undetected in our re-sequencing panels of 32 or 96 case DNAs. However, the re-sequencing of several hundred cases and controls is beyond the scope of the present study in which we have investigated variants with MAF &#x02265; 0.03.</p></sec><sec><title>Conclusion</title><p>Taken together, these data make an association between type 1 diabetes and common variation in coding and untranslated regions of the six functional candidate genes in the investigated human-mouse orthologue regions less likely. Several possibilities may account for this. A gene (or several genes) in an <italic>Idd </italic>interval may account for disease susceptibility in the NOD mouse, but the human orthologous region may lack this susceptibility variant. The scenario, in which candidate genes in the NOD <italic>Idd </italic>interval may not necessarily be harbouring a functional, causal variant in their human orthologue genes, was discussed previously [<xref ref-type="bibr" rid="B25">25</xref>]. It is also possible that the selected candidate gene in the <italic>Idd </italic>interval may not be the gene causing susceptibility to disease.</p><p>The tag SNP maps described here will be useful for association studies of other diseases. They will be integrated into future SNP maps encompassing the entire orthologous regions and all regulatory sequences and genes encoded within them.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>All family members were white and of European ancestral origin. The type 1 diabetes families comprised two parents and a least one affected child. The 748 type 1 diabetes families used in 'step 1' were as described previously [<xref ref-type="bibr" rid="B26">26</xref>]: 472 UK Warren 1 multiplex and 276 multiplex Human Biological Data Interchange families ascertained in the U.S.A. The case-control DNA set for the tag SNP approach consisted of 1,709 Caucasian type 1 diabetes cases, which were recruited from across Britain in the Juvenile Diabetes Research Foundation/Wellcome Trust funded UK Genetic Resource Investigating Diabetes (GRID) study [<xref ref-type="bibr" rid="B27">27</xref>], and 1,829 population-based controls from the 1958 British Birth Cohort (BBC) [<xref ref-type="bibr" rid="B28">28</xref>]. The mean age-at-onset of the cases, with almost all under 16 years of age at diagnosis, is 7.5 years (with a standard deviation of 4 years). The 1958 BBC controls are part of an ongoing longitudinal study and the subjects are British citizens born in a particular week in 1958. In order to test association for type 1 diabetes susceptibility and the rare variants in <italic>CD101 </italic>and <italic>NRAMP1</italic>, DIL3799/ss23142349 and DIL5202/ss23142243, a total of 3,704 type 1 diabetes cases and 3,930 controls were used.</p><p>For 'step 2' genotyping of <italic>NRAMP1</italic>, the 748 type 1 diabetes families described above were used in addition to 343 multiplex/simplex families from the UK, 159 Norwegian simplex families, 322 Romanian simplex families, and 60 multiplex families from the USA totalling the combined DNA sets to 1,632 type 1 diabetes families, as described previously [<xref ref-type="bibr" rid="B26">26</xref>].</p></sec><sec><title>Sequencing</title><p>Nested PCR products from DNA from 96 or 32 type 1 diabetes patients were sequenced using an Applied Biosystems (ABI) 3700 capillary sequencer (Foster City, CA), and SNPs identified using the Staden Package [<xref ref-type="bibr" rid="B29">29</xref>].</p></sec><sec><title>Genotyping</title><p>SNPs were genotyped using the Invader<sup>&#x000ae; </sup>assay (Third Wave Technologies, Inc. Madison WI) [<xref ref-type="bibr" rid="B30">30</xref>] and TaqMan MGB chemistry (ABI) [<xref ref-type="bibr" rid="B31">31</xref>]. The <italic>NRAMP1 </italic>microsatellite was genotyped on an ABI3700 sequencer using fluorescent primers as previously described [<xref ref-type="bibr" rid="B32">32</xref>]. Full details of primers and probes used for genotyping are available upon request. All genotyping data was double-scored independently.</p></sec><sec><title>Annotation</title><p>Annotation of <italic>NRAMP1 </italic>(European Molecular Biology Laboratory [EMBL] accession numbers D50402, D50403, BC041787, L32185, BC033754), <italic>FRAP1 </italic>(UO88966), <italic>4-1BB </italic>(UO3387), <italic>CD101 </italic>(Z33642), <italic>B2M </italic>(BC032589) and <italic>VAV3 </italic>(AF118887, <italic>VAV3</italic>; AF118886, <italic>VAV3&#x003b2;</italic>; AF118887, <italic>VAV3.1</italic>) was performed by importing Ensembl information into a temporary ACeDB database as described in Burren <italic>et al. </italic>[<xref ref-type="bibr" rid="B33">33</xref>]. After confirmation of gene structures by BLAST analysis, these were re-extracted in GFF format and submitted to a local Gbrowse database (National Center for Biotechnology Information build 34) (DIL annotations viewable at T1DBase [<xref ref-type="bibr" rid="B34">34</xref>].</p></sec><sec><title>Statistical analysis</title><p>The program for the selection of tag SNPs [<xref ref-type="bibr" rid="B17">17</xref>] and association analysis used here are implemented in the <italic>Stata </italic>statistical system and may be downloaded from our website [<xref ref-type="bibr" rid="B35">35</xref>]. All genotyping data were in Hardy-Weinberg equilibrium (<italic>P </italic>&#x0003e; 0.05).</p></sec></sec><sec><title>Authors' contributions</title><p>LMM and DJS contributed equally to this work by performing the genetic studies and writing the manuscript. AV, FP, RP, CL, JH, HF, CM, KMH, GC carried out the genetic studies and collated data. JDC performed the statistical analysis and participated in the design of the study. LJS participated in the sequence analysis. NW participated in design and collated data. KSR, CG, C I-T, DAS, DPS and LBP participated in the study design and coordination. JAT, LSW and RCT helped to draft the manuscript. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S2"><caption><title>Additional File 2</title><p>SNPs, including two deletion/insertion polymorphisms, identified in <italic>NRAMP1</italic>. Novel SNPs are denoted by "ss" numbers and previously published SNPs are denoted by "rs" numbers. Minor allele frequencies are based on the sequencing panel of 32 type 1 diabetes subjects. <italic>R</italic><sup>2 </sup>values for non-typed SNPs. UTR, untranslated region.</p></caption><media xlink:href="1471-2156-6-9-S2.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S5"><caption><title>Additional File 5</title><p>SNPs identified in <italic>CD101</italic>. Novel SNPs are denoted by "ss" numbers and previously published SNPs are denoted by "rs" numbers. Minor allele frequencies are based on the sequencing panel of 96 type 1 diabetes subjects. <italic>R</italic><sup>2 </sup>values for non-typed SNPs. Note that DIL3969 has an allelic <italic>R</italic><sup>2 </sup>&#x0003c; 0.80 due to technical difficulties with the assay. UTR, untranslated region.</p></caption><media xlink:href="1471-2156-6-9-S5.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S7"><caption><title>Additional File 7</title><p>SNPs, including four in/dels identified in <italic>VAV3</italic>. Novel SNPs are denoted by "ss" numbers and previously published SNPs are denoted by "rs" numbers. Minor allele frequencies are based on the sequencing panel of 96 type 1 diabetes subjects. <italic>R</italic><sup>2 </sup>values for non-typed SNPs. Note that DIL6496 and DIL6488 in block 1, and DIL1526 have allelic <italic>R</italic><sup>2 </sup>values &#x0003c; 0.80, which was due to technical difficulties with those assays. UTR, untranslated region.</p></caption><media xlink:href="1471-2156-6-9-S7.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S1"><caption><title>Additional File 1</title><p>Supporting published references for Table <xref ref-type="table" rid="T1">1</xref>. NOD mouse <italic>Idd </italic>loci, the location of their human orthologous regions, and selected functional candidate gene within the <italic>Idd </italic>interval. *Estimated number of genes.</p></caption><media xlink:href="1471-2156-6-9-S1.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional File 3</title><p>SNPs identified in <italic>4-1BB</italic>. Minor allele frequencies are based on the sequencing panel of 96 type 1 diabetes subjects. Novel SNPs are denoted by "ss" numbers and previously published SNPs are denoted by "rs" numbers. Note that DIL4247/rs6694557 could not be genotyped due to assay technical difficulties. UTR, untranslated region.</p></caption><media xlink:href="1471-2156-6-9-S3.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S4"><caption><title>Additional File 4</title><p>SNPs identified in <italic>FRAP1</italic>. Novel SNPs are denoted by "ss" numbers and previously published SNPs are denoted by "rs" numbers. Minor allele frequencies are based on the sequencing panel of 32 type 1 diabetes subjects. <italic>R</italic><sup>2 </sup>values for non-typed SNPs. UTR, untranslated region.</p></caption><media xlink:href="1471-2156-6-9-S4.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S6"><caption><title>Additional File 6</title><p>SNPs identified in <italic>B2M</italic>. Novel SNPs are denoted by "ss" numbers and previously published SNPs are denoted by "rs" numbers. Minor allele frequencies are based on the sequencing panel of 32 type 1 diabetes subjects. <italic>R</italic><sup>2 </sup>values for non-typed SNPs. UTR, untranslated region.</p></caption><media xlink:href="1471-2156-6-9-S6.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S8"><caption><title>Additional File 8</title><p>Genotyping counts Numbers of attempted subjects for genotyping and of subjects with genotypes.</p></caption><media xlink:href="1471-2156-6-9-S8.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was funded by the Wellcome Trust and the Juvenile Diabetes Research Foundation International. L.M.M. was the recipient of a Wellcome Trust Prize Studentship. A.V. was a Mayo Foundation Scholar. We thank the Human Biological Data Interchange and Diabetes U.K. for USA and U.K. multiplex families, respectively and the Norwegian Study Group for Childhood Diabetes for the collection of Norwegian families. We acknowledge use of DNA from the 1958 British Birth Cohort collection, funded by the Medical Research Council grant G0000934 and Wellcome Trust grant 068545/Z/02. DNA samples were prepared by Jayne Hutchings, Gillian Coleman, Trupti Mistry, Kirsi Bourget, Sally Clayton, Matthew Hardy, Jennifer Keylock, Pamela Lauder, Meeta Maisuria, William Meadows, Meera Sebastian, Sarah Wood, The Avon Longitudinal Study of Parents and Children laboratory in Bristol, including Susan Ring, Wendy McArdle, Richard Jones, for preparing DNA samples.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Bell</surname><given-names>JI</given-names></name><name><surname>McDevitt</surname><given-names>HO</given-names></name></person-group><article-title>HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus</article-title><source>Nature</source><year>1987</year><volume>329</volume><fpage>599</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">3309680</pub-id><pub-id pub-id-type="doi">10.1038/329599a0</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Armitage</surname><given-names>N</given-names></name><name><surname>Argentina</surname><given-names>F</given-names></name><name><surname>Denny</surname><given-names>P</given-names></name><name><surname>Hill</surname><given-names>NJ</given-names></name><name><surname>Lord</surname><given-names>CJ</given-names></name><name><surname>Wilusz</surname><given-names>MB</given-names></name><name><surname>Peterson</surname><given-names>LB</given-names></name><name><surname>Wicker</surname><given-names>LS</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Congenic mapping of the type 1 diabetes locus, <italic>Idd3</italic>, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping</article-title><source>Genome Res</source><year>2000</year><volume>10</volume><fpage>446</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">10779485</pub-id><pub-id pub-id-type="doi">10.1101/gr.10.4.446</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wicker</surname><given-names>LS</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Peterson</surname><given-names>LB</given-names></name></person-group><article-title>Genetic control of autoimmune diabetes in the NOD mouse</article-title><source>Annu Rev Immunol</source><year>1995</year><volume>13</volume><fpage>179</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">7612220</pub-id><pub-id pub-id-type="doi">10.1146/annurev.iy.13.040195.001143</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serreze</surname><given-names>DV</given-names></name><name><surname>Leiter</surname><given-names>EH</given-names></name></person-group><article-title>Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice</article-title><source>Curr Dir Autoimmun</source><year>2001</year><volume>4</volume><fpage>31</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">11569409</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colle</surname><given-names>E</given-names></name><name><surname>Guttmann</surname><given-names>RD</given-names></name><name><surname>Seemayer</surname><given-names>T</given-names></name></person-group><article-title>Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex</article-title><source>J Exp Med</source><year>1981</year><volume>154</volume><fpage>1237</fpage><lpage>1242</lpage><pub-id pub-id-type="pmid">7026724</pub-id><pub-id pub-id-type="doi">10.1084/jem.154.4.1237</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>HJ</given-names></name><name><surname>Pettersson</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>D</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Lernmark</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name></person-group><article-title>Genetic dissection of autoimmune type I diabetes in the BB rat</article-title><source>Nat Genet</source><year>1992</year><volume>2</volume><fpage>56</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">1303251</pub-id><pub-id pub-id-type="doi">10.1038/ng0992-56</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacMurray</surname><given-names>AJ</given-names></name><name><surname>Moralejo</surname><given-names>DH</given-names></name><name><surname>Kwitek</surname><given-names>AE</given-names></name><name><surname>Rutledge</surname><given-names>EA</given-names></name><name><surname>Van Yserloo</surname><given-names>B</given-names></name><name><surname>Gohlke</surname><given-names>P</given-names></name><name><surname>Speros</surname><given-names>SJ</given-names></name><name><surname>Snyder</surname><given-names>B</given-names></name><name><surname>Schaefer</surname><given-names>J</given-names></name><name><surname>Bieg</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Ettinger</surname><given-names>RA</given-names></name><name><surname>Fuller</surname><given-names>J</given-names></name><name><surname>Daniels</surname><given-names>TL</given-names></name><name><surname>Pettersson</surname><given-names>A</given-names></name><name><surname>Orlebeke</surname><given-names>K</given-names></name><name><surname>Birren</surname><given-names>B</given-names></name><name><surname>Jacob</surname><given-names>HJ</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Lernmark</surname><given-names>A</given-names></name></person-group><article-title>Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene</article-title><source>Genome Res</source><year>2002</year><volume>12</volume><fpage>1029</fpage><lpage>1039</lpage><pub-id pub-id-type="pmid">12097339</pub-id><pub-id pub-id-type="doi">10.1101/gr.412702</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yokoi</surname><given-names>N</given-names></name><name><surname>Komeda</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Yano</surname><given-names>H</given-names></name><name><surname>Kitada</surname><given-names>K</given-names></name><name><surname>Saitoh</surname><given-names>Y</given-names></name><name><surname>Seino</surname><given-names>Y</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Serikawa</surname><given-names>T</given-names></name><name><surname>Seino</surname><given-names>S</given-names></name></person-group><article-title><italic>Cblb </italic>is a major susceptibility gene for rat type 1 diabetes mellitus</article-title><source>Nat Genet</source><year>2002</year><volume>31</volume><fpage>391</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">12118252</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ueda</surname><given-names>H</given-names></name><name><surname>Howson</surname><given-names>JM</given-names></name><name><surname>Esposito</surname><given-names>L</given-names></name><name><surname>Heward</surname><given-names>J</given-names></name><name><surname>Snook</surname><given-names>H</given-names></name><name><surname>Chamberlain</surname><given-names>G</given-names></name><name><surname>Rainbow</surname><given-names>DB</given-names></name><name><surname>Hunter</surname><given-names>KM</given-names></name><name><surname>Smith</surname><given-names>AN</given-names></name><name><surname>Di Genova</surname><given-names>G</given-names></name><name><surname>Herr</surname><given-names>MH</given-names></name><name><surname>Dahlman</surname><given-names>I</given-names></name><name><surname>Payne</surname><given-names>F</given-names></name><name><surname>Smyth</surname><given-names>D</given-names></name><name><surname>Lowe</surname><given-names>C</given-names></name><name><surname>Twells</surname><given-names>RC</given-names></name><name><surname>Howlett</surname><given-names>S</given-names></name><name><surname>Healy</surname><given-names>B</given-names></name><name><surname>Nutland</surname><given-names>S</given-names></name><name><surname>Rance</surname><given-names>HE</given-names></name><name><surname>Everett</surname><given-names>V</given-names></name><name><surname>Smink</surname><given-names>LJ</given-names></name><name><surname>Lam</surname><given-names>AC</given-names></name><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>Walker</surname><given-names>NM</given-names></name><name><surname>Bordin</surname><given-names>C</given-names></name><name><surname>Hulme</surname><given-names>J</given-names></name><name><surname>Motzo</surname><given-names>C</given-names></name><name><surname>Cucca</surname><given-names>F</given-names></name><name><surname>Hess</surname><given-names>JF</given-names></name><name><surname>Metzker</surname><given-names>ML</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Gregory</surname><given-names>S</given-names></name><name><surname>Allahabadia</surname><given-names>A</given-names></name><name><surname>Nithiyananthan</surname><given-names>R</given-names></name><name><surname>Tuomilehto-Wolf</surname><given-names>E</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Bingley</surname><given-names>P</given-names></name><name><surname>Gillespie</surname><given-names>KM</given-names></name><name><surname>Undlien</surname><given-names>DE</given-names></name><name><surname>Ronningen</surname><given-names>KS</given-names></name><name><surname>Guja</surname><given-names>C</given-names></name><name><surname>Ionescu-Tirgoviste</surname><given-names>C</given-names></name><name><surname>Savage</surname><given-names>DA</given-names></name><name><surname>Maxwell</surname><given-names>AP</given-names></name><name><surname>Carson</surname><given-names>DJ</given-names></name><name><surname>Patterson</surname><given-names>CC</given-names></name><name><surname>Franklyn</surname><given-names>JA</given-names></name><name><surname>Clayton</surname><given-names>DG</given-names></name><name><surname>Peterson</surname><given-names>LB</given-names></name><name><surname>Wicker</surname><given-names>LS</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Gough</surname><given-names>SC</given-names></name></person-group><article-title>Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease</article-title><source>Nature</source><year>2003</year><volume>423</volume><fpage>506</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">12724780</pub-id><pub-id pub-id-type="doi">10.1038/nature01621</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Penha-Goncalves</surname><given-names>C</given-names></name><name><surname>Moule</surname><given-names>C</given-names></name><name><surname>Smink</surname><given-names>LJ</given-names></name><name><surname>Howson</surname><given-names>J</given-names></name><name><surname>Gregory</surname><given-names>S</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Suttie</surname><given-names>JJ</given-names></name><name><surname>Lord</surname><given-names>CJ</given-names></name><name><surname>Peterson</surname><given-names>LB</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Wicker</surname><given-names>LS</given-names></name></person-group><article-title>Identification of a structurally distinct CD101 molecule encoded in the 950-kb <italic>Idd10 </italic>region of NOD mice</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>1551</fpage><lpage>1556</lpage><pub-id pub-id-type="pmid">12765969</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wicker</surname><given-names>LS</given-names></name><name><surname>Chamberlain</surname><given-names>G</given-names></name><name><surname>Hunter</surname><given-names>K</given-names></name><name><surname>Rainbow</surname><given-names>D</given-names></name><name><surname>Howlett</surname><given-names>S</given-names></name><name><surname>Tiffen</surname><given-names>P</given-names></name><name><surname>Clark</surname><given-names>J</given-names></name><name><surname>Gonzalez-Munoz</surname><given-names>A</given-names></name><name><surname>Cumiskey</surname><given-names>AM</given-names></name><name><surname>Rosa</surname><given-names>RL</given-names></name><name><surname>Howson</surname><given-names>JM</given-names></name><name><surname>Smink</surname><given-names>LJ</given-names></name><name><surname>Kingsnorth</surname><given-names>A</given-names></name><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Gregory</surname><given-names>S</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Peterson</surname><given-names>LB</given-names></name></person-group><article-title>Fine mapping, gene content, comparative sequencing, and expression analyses support <italic>Ctla4 </italic>and <italic>Nramp1 </italic>as candidates for <italic>Idd5.1 </italic>and <italic>Idd5.2 </italic>in the nonobese diabetic mouse</article-title><source>J Immunol</source><year>2004</year><volume>173</volume><fpage>164</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">15210771</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Hancock</surname><given-names>WW</given-names></name><name><surname>Denny</surname><given-names>P</given-names></name><name><surname>Lord</surname><given-names>CJ</given-names></name><name><surname>Hill</surname><given-names>NJ</given-names></name><name><surname>Armitage</surname><given-names>N</given-names></name><name><surname>Siegmund</surname><given-names>T</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Phillips</surname><given-names>MS</given-names></name><name><surname>Hess</surname><given-names>JF</given-names></name><name><surname>Chen</surname><given-names>SL</given-names></name><name><surname>Fischer</surname><given-names>PA</given-names></name><name><surname>Peterson</surname><given-names>LB</given-names></name><name><surname>Wicker</surname><given-names>LS</given-names></name></person-group><article-title>The NOD <italic>Idd9 </italic>genetic interval influences the pathogenicity of insulitis and contains molecular variants of <italic>Cd30</italic>, <italic>Tnfr2</italic>, and <italic>Cd137</italic></article-title><source>Immunity</source><year>2000</year><volume>13</volume><fpage>107</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">10933399</pub-id><pub-id pub-id-type="doi">10.1016/S1074-7613(00)00012-1</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serreze</surname><given-names>DV</given-names></name><name><surname>Bridgett</surname><given-names>M</given-names></name><name><surname>Chapman</surname><given-names>HD</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Richard</surname><given-names>SD</given-names></name><name><surname>Leiter</surname><given-names>EH</given-names></name></person-group><article-title>Subcongenic analysis of the <italic>Idd13 </italic>locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin</article-title><source>J Immunol</source><year>1998</year><volume>160</volume><fpage>1472</fpage><lpage>1478</lpage><pub-id pub-id-type="pmid">9570569</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>PA</given-names></name><name><surname>Armitage</surname><given-names>N</given-names></name><name><surname>Lord</surname><given-names>CJ</given-names></name><name><surname>Phillips</surname><given-names>MS</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Peterson</surname><given-names>LB</given-names></name><name><surname>Wicker</surname><given-names>LS</given-names></name></person-group><article-title>Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci <italic>Idd10 </italic>and <italic>Idd18 </italic>in the NOD mouse</article-title><source>Diabetes</source><year>2001</year><volume>50</volume><fpage>2633</fpage><lpage>2637</lpage><pub-id pub-id-type="pmid">11679445</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamilton-Williams</surname><given-names>EE</given-names></name><name><surname>Serreze</surname><given-names>DV</given-names></name><name><surname>Charlton</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>EA</given-names></name><name><surname>Marron</surname><given-names>MP</given-names></name><name><surname>Mullbacher</surname><given-names>A</given-names></name><name><surname>Slattery</surname><given-names>RM</given-names></name></person-group><article-title>Transgenic rescue implicates beta2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>11533</fpage><lpage>11538</lpage><pub-id pub-id-type="pmid">11572996</pub-id><pub-id pub-id-type="doi">10.1073/pnas.191383798</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>GC</given-names></name><name><surname>Esposito</surname><given-names>L</given-names></name><name><surname>Barratt</surname><given-names>BJ</given-names></name><name><surname>Smith</surname><given-names>AN</given-names></name><name><surname>Heward</surname><given-names>J</given-names></name><name><surname>Di Genova</surname><given-names>G</given-names></name><name><surname>Ueda</surname><given-names>H</given-names></name><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>Eaves</surname><given-names>IA</given-names></name><name><surname>Dudbridge</surname><given-names>F</given-names></name><name><surname>Twells</surname><given-names>RC</given-names></name><name><surname>Payne</surname><given-names>F</given-names></name><name><surname>Hughes</surname><given-names>W</given-names></name><name><surname>Nutland</surname><given-names>S</given-names></name><name><surname>Stevens</surname><given-names>H</given-names></name><name><surname>Carr</surname><given-names>P</given-names></name><name><surname>Tuomilehto-Wolf</surname><given-names>E</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Gough</surname><given-names>SC</given-names></name><name><surname>Clayton</surname><given-names>DG</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Haplotype tagging for the identification of common disease genes</article-title><source>Nat Genet</source><year>2001</year><volume>29</volume><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">11586306</pub-id><pub-id pub-id-type="doi">10.1038/ng1001-233</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>JM</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Clayton</surname><given-names>DG</given-names></name></person-group><article-title>Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power</article-title><source>Hum Hered</source><year>2003</year><volume>56</volume><fpage>18</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">14614235</pub-id><pub-id pub-id-type="doi">10.1159/000073729</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Searle</surname><given-names>S</given-names></name><name><surname>Blackwell</surname><given-names>JM</given-names></name></person-group><article-title>Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility</article-title><source>J Med Genet</source><year>1999</year><volume>36</volume><fpage>295</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">10227396</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanjeevi</surname><given-names>CB</given-names></name><name><surname>Miller</surname><given-names>EN</given-names></name><name><surname>Dabadghao</surname><given-names>P</given-names></name><name><surname>Rumba</surname><given-names>I</given-names></name><name><surname>Shtauvere</surname><given-names>A</given-names></name><name><surname>Denisova</surname><given-names>A</given-names></name><name><surname>Clayton</surname><given-names>D</given-names></name><name><surname>Blackwell</surname><given-names>JM</given-names></name></person-group><article-title>Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis</article-title><source>Arthritis Rheum</source><year>2000</year><volume>43</volume><fpage>1397</fpage><lpage>1404</lpage><pub-id pub-id-type="pmid">10857800</pub-id><pub-id pub-id-type="doi">10.1002/1529-0131(200006)43:6&#x0003c;1397::AID-ANR25&#x0003e;3.0.CO;2-6</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>L</given-names></name><name><surname>Hill</surname><given-names>NJ</given-names></name><name><surname>Pritchard</surname><given-names>LE</given-names></name><name><surname>Cucca</surname><given-names>F</given-names></name><name><surname>Muxworthy</surname><given-names>C</given-names></name><name><surname>Merriman</surname><given-names>ME</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Julier</surname><given-names>C</given-names></name><name><surname>Delepine</surname><given-names>M</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Tuomilehto-Wolf</surname><given-names>E</given-names></name><name><surname>Ionesco-Tirgoviste</surname><given-names>C</given-names></name><name><surname>Nistico</surname><given-names>L</given-names></name><name><surname>Buzzetti</surname><given-names>R</given-names></name><name><surname>Pozzilli</surname><given-names>P</given-names></name><name><surname>Ferrari</surname><given-names>M</given-names></name><name><surname>Bosi</surname><given-names>E</given-names></name><name><surname>Pociot</surname><given-names>F</given-names></name><name><surname>Nerup</surname><given-names>J</given-names></name><name><surname>Bain</surname><given-names>SC</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci <italic>IDDM7</italic>, <italic>IDDM12</italic>, and <italic>IDDM13 </italic>and candidate genes <italic>NRAMP1 </italic>and <italic>IA-2 </italic>and the interleukin-1 gene cluster. IMDIAB Group</article-title><source>Diabetes</source><year>1998</year><volume>47</volume><fpage>1797</fpage><lpage>1799</lpage><pub-id pub-id-type="pmid">9792551</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Consortium</surname><given-names>TIH</given-names></name></person-group><article-title>The International HapMap Project</article-title><source>Nature</source><year>2003</year><volume>426</volume><fpage>789</fpage><lpage>796</lpage><pub-id pub-id-type="pmid">14685227</pub-id><pub-id pub-id-type="doi">10.1038/nature02168</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>CE</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Chapman</surname><given-names>JM</given-names></name><name><surname>Barratt</surname><given-names>BJ</given-names></name><name><surname>Twells</surname><given-names>RC</given-names></name><name><surname>Green</surname><given-names>EA</given-names></name><name><surname>Savage</surname><given-names>DA</given-names></name><name><surname>Guja</surname><given-names>C</given-names></name><name><surname>Ionescu-Tirgoviste</surname><given-names>C</given-names></name><name><surname>Tuomilehto-Wolf</surname><given-names>E</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Clayton</surname><given-names>DG</given-names></name></person-group><article-title>Cost-effective analysis of candidate genes using htSNPs: a staged approach</article-title><source>Genes Immun</source><year>2004</year><volume>5</volume><fpage>301</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">15029236</pub-id><pub-id pub-id-type="doi">10.1038/sj.gene.6364064</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>NJ</given-names></name><name><surname>Wapelhorst</surname><given-names>B</given-names></name><name><surname>Morrison</surname><given-names>VA</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name><name><surname>Pinchuk</surname><given-names>L</given-names></name><name><surname>Spielman</surname><given-names>RS</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Concannon</surname><given-names>P</given-names></name></person-group><article-title>Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families</article-title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>820</fpage><lpage>830</lpage><pub-id pub-id-type="pmid">11507694</pub-id><pub-id pub-id-type="doi">10.1086/323501</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>JC</given-names></name><name><surname>Kiss</surname><given-names>RS</given-names></name><name><surname>Pertsemlidis</surname><given-names>A</given-names></name><name><surname>Marcel</surname><given-names>YL</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Hobbs</surname><given-names>HH</given-names></name></person-group><article-title>Multiple rare alleles contribute to low plasma levels of HDL cholesterol</article-title><source>Science</source><year>2004</year><volume>305</volume><fpage>869</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">15297675</pub-id><pub-id pub-id-type="doi">10.1126/science.1099870</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Risch</surname><given-names>N</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM)</article-title><source>Am J Hum Genet</source><year>1993</year><volume>53</volume><fpage>702</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">8352278</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vella</surname><given-names>A</given-names></name><name><surname>Howson</surname><given-names>JM</given-names></name><name><surname>Barratt</surname><given-names>BJ</given-names></name><name><surname>Twells</surname><given-names>RC</given-names></name><name><surname>Rance</surname><given-names>HE</given-names></name><name><surname>Nutland</surname><given-names>S</given-names></name><name><surname>Tuomilehto-Wolf</surname><given-names>E</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Undlien</surname><given-names>DE</given-names></name><name><surname>Ronningen</surname><given-names>KS</given-names></name><name><surname>Guja</surname><given-names>C</given-names></name><name><surname>Ionescu-Tirgoviste</surname><given-names>C</given-names></name><name><surname>Savage</surname><given-names>DA</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>1158</fpage><lpage>1161</lpage><pub-id pub-id-type="pmid">15047635</pub-id></citation></ref><ref id="B27"><citation citation-type="other"><article-title>UK Genetic Resource Investigating Diabetes (GRID) study</article-title><ext-link ext-link-type="uri" xlink:href="http://www-gene.cimr.cam.ac.uk/ucdr/grid.shtml"/></citation></ref><ref id="B28"><citation citation-type="other"><article-title>1958 British Birth Cohort</article-title><ext-link ext-link-type="uri" xlink:href="http://www.cls.ioe.ac.uk/Cohort/Ncds/mainncds.html"/></citation></ref><ref id="B29"><citation citation-type="other"><article-title>Staden Package</article-title><ext-link ext-link-type="uri" xlink:href="http://www.mrc-lmb.cam.ac.uk/pubseq/"/></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olivier</surname><given-names>M</given-names></name><name><surname>Chuang</surname><given-names>LM</given-names></name><name><surname>Chang</surname><given-names>MS</given-names></name><name><surname>Chen</surname><given-names>YT</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name><name><surname>Ranade</surname><given-names>K</given-names></name><name><surname>de Witte</surname><given-names>A</given-names></name><name><surname>Allen</surname><given-names>J</given-names></name><name><surname>Tran</surname><given-names>N</given-names></name><name><surname>Curb</surname><given-names>D</given-names></name><name><surname>Pratt</surname><given-names>R</given-names></name><name><surname>Neefs</surname><given-names>H</given-names></name><name><surname>de Arruda Indig</surname><given-names>M</given-names></name><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Neri</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Cox</surname><given-names>DR</given-names></name></person-group><article-title>High-throughput genotyping of single nucleotide polymorphisms using new biplex invader technology</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>e53</fpage><pub-id pub-id-type="pmid">12060691</pub-id><pub-id pub-id-type="doi">10.1093/nar/gnf052</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranade</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>MS</given-names></name><name><surname>Ting</surname><given-names>CT</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name><name><surname>Hsiao</surname><given-names>CF</given-names></name><name><surname>Olivier</surname><given-names>M</given-names></name><name><surname>Pesich</surname><given-names>R</given-names></name><name><surname>Hebert</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>YD</given-names></name><name><surname>Dzau</surname><given-names>VJ</given-names></name><name><surname>Curb</surname><given-names>D</given-names></name><name><surname>Olshen</surname><given-names>R</given-names></name><name><surname>Risch</surname><given-names>N</given-names></name><name><surname>Cox</surname><given-names>DR</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name></person-group><article-title>High-throughput genotyping with single nucleotide polymorphisms</article-title><source>Genome Res</source><year>2001</year><volume>11</volume><fpage>1262</fpage><lpage>1268</lpage><pub-id pub-id-type="pmid">11435409</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>AM</given-names></name><name><surname>Dollinger</surname><given-names>MM</given-names></name><name><surname>Howie</surname><given-names>SE</given-names></name><name><surname>Harrison</surname><given-names>DJ</given-names></name></person-group><article-title>Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: analysis of allele frequencies in primary biliary cirrhosis</article-title><source>J Med Genet</source><year>2000</year><volume>37</volume><fpage>150</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">10712108</pub-id><pub-id pub-id-type="doi">10.1136/jmg.37.2.150</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burren</surname><given-names>OS</given-names></name><name><surname>Healy</surname><given-names>BC</given-names></name><name><surname>Lam</surname><given-names>AC</given-names></name><name><surname>Schuilenburg</surname><given-names>H</given-names></name><name><surname>Dolman</surname><given-names>GE</given-names></name><name><surname>Everett</surname><given-names>VH</given-names></name><name><surname>Laneri</surname><given-names>D</given-names></name><name><surname>Nutland</surname><given-names>S</given-names></name><name><surname>Rance</surname><given-names>HE</given-names></name><name><surname>Payne</surname><given-names>F</given-names></name><name><surname>Smyth</surname><given-names>D</given-names></name><name><surname>Lowe</surname><given-names>C</given-names></name><name><surname>Barratt</surname><given-names>BJ</given-names></name><name><surname>Twells</surname><given-names>RC</given-names></name><name><surname>Rainbow</surname><given-names>DB</given-names></name><name><surname>Wicker</surname><given-names>LS</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Walker</surname><given-names>NM</given-names></name><name><surname>Smink</surname><given-names>LJ</given-names></name></person-group><article-title>Development of an integrated genome informatics, data management and workflow infrastructure: a toolbox for the study of complex disease genetics</article-title><source>Hum Genomics</source><year>2004</year><volume>1</volume><fpage>98</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">15601538</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smink</surname><given-names>LJ</given-names></name><name><surname>Helton</surname><given-names>EM</given-names></name><name><surname>Healy</surname><given-names>BC</given-names></name><name><surname>Cavnor</surname><given-names>CC</given-names></name><name><surname>Lam</surname><given-names>AC</given-names></name><name><surname>Flamez</surname><given-names>D</given-names></name><name><surname>Burren</surname><given-names>OS</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Dolman</surname><given-names>GE</given-names></name><name><surname>Burdick</surname><given-names>DB</given-names></name><name><surname>Everett</surname><given-names>VH</given-names></name><name><surname>Glusman</surname><given-names>G</given-names></name><name><surname>Laneri</surname><given-names>D</given-names></name><name><surname>Rowen</surname><given-names>L</given-names></name><name><surname>Schuilenburg</surname><given-names>H</given-names></name><name><surname>Walker</surname><given-names>NM</given-names></name><name><surname>Mychaleckyj</surname><given-names>J</given-names></name><name><surname>Wicker</surname><given-names>LS</given-names></name><name><surname>Eizirik</surname><given-names>DL</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Goodman</surname><given-names>N</given-names></name></person-group><article-title>T1DBase, a community web-based resource for type 1 diabetes research</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>D544</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">15608258</pub-id><pub-id pub-id-type="doi">10.1093/nar/gki095</pub-id></citation></ref><ref id="B35"><citation citation-type="other"><article-title>Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory</article-title><ext-link ext-link-type="uri" xlink:href="http://www-gene.cimr.cam.ac.uk/clayton/software/stata"/></citation></ref></ref-list></back></article>



